Collaboration enables deployment of MaxYield™ and CardioYield™ into third-party health systems and clinic sites This pilot expands the Movesense collaboration to scale low-cost, AI-powered 1-lead ECG ...
HeartBeam has submitted a 510(k) application to the US Food and Drug Administration (FDA) for its 12-lead electrocardiogram (ECG) synthesis software tailored to assess various cardiac rhythms and ...
Hosted on MSN
HeartBeam (NASDAQ: BEAT) secures FDA 510(k) clearance for 12-lead ECG synthesis software following successful appeal
HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized insights, received FDA 510(k) clearance for its 12-lead ECG synthesis software for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results